TSPO and juvenile Huntington disease: In the past, the TSPO radiotracer ligand [11C]PK11195 was successfully applied to depict glial activation in various CNS diseases like multiple sclerosis, Huntington’s disease, amyotrophic lateral sclerosis, Alzheimer’s disease, traumatic brain injury, and ischemic stroke (32–35).